An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study by Peter Barlis, Evelyn Regar, Patrick W. Serruys, Konstantinos Dimopoulos, Willem J. van der Giessen, Robert-Jan M. van Geuns, Giuseppe Ferrante, Simon Wandel, Stephan Windecker, Gerrit-Anne van Es, Pedro Eerdmans, Peter Jüni, and Carlo di Mario EHJ Volume 31(2): January 14, 2010 Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please
Trial profile. ¶Two patients allocated to sirolimus-eluting stents and clinical follow-up only (two lesions) had a clinically indicated angiography and underwent optical coherence tomography; *One patient allocated to biolimus-eluting stents (two lesions) had one lesion excluded from the analysis for technical reasons; †Two patients allocated to sirolimus-eluting stents (four lesions) had one lesion excluded each from the analysis for technical reasons. Peter Barlis et al. Eur Heart J 2010;31: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please
Examples of optical coherence tomography findings. Peter Barlis et al. Eur Heart J 2010;31: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please
Graphical representation of stent coverage in lesions. Peter Barlis et al. Eur Heart J 2010;31: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please
Distribution of neointimal thickness. Peter Barlis et al. Eur Heart J 2010;31: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author For permissions please